GPX4 and neoplasm: Recently, dual hypoxia-sensitive polymeric nanocarriers have been designed to sensitize hypoxic tumor cells to ferroptosis by depleting NADPH, GSH, and Trx, thereby inhibiting GPX4 activity and enhancing the efficacy of ferroptosis-inducing agents, specifically in hypoxic tumors [31,32].